持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/02/15 | 8,380 | 8,430 | 8,230 | 8,380 | +100 | +1.2% | 56,900 |
| 2017/02/14 | 8,350 | 8,370 | 8,280 | 8,280 | -50 | -0.6% | 35,000 |
| 2017/02/13 | 8,380 | 8,400 | 8,270 | 8,330 | +30 | +0.4% | 50,200 |
| 2017/02/10 | 8,250 | 8,370 | 8,250 | 8,300 | +150 | +1.8% | 41,100 |
| 2017/02/09 | 8,190 | 8,200 | 8,130 | 8,150 | ±0 | ±0% | 23,500 |
| 2017/02/08 | 8,180 | 8,180 | 8,090 | 8,150 | -60 | -0.7% | 21,700 |
| 2017/02/07 | 8,160 | 8,260 | 8,150 | 8,210 | -10 | -0.1% | 31,100 |
| 2017/02/06 | 8,210 | 8,240 | 8,140 | 8,220 | -10 | -0.1% | 28,600 |
| 2017/02/03 | 8,020 | 8,260 | 8,020 | 8,230 | +210 | +2.6% | 41,500 |
| 2017/02/02 | 8,140 | 8,210 | 8,000 | 8,020 | -120 | -1.5% | 36,200 |
| 2017/02/01 | 8,020 | 8,140 | 7,980 | 8,140 | +50 | +0.6% | 36,200 |
| 2017/01/31 | 8,050 | 8,150 | 8,020 | 8,090 | +40 | +0.5% | 27,800 |
| 2017/01/30 | 7,990 | 8,200 | 7,960 | 8,050 | ±0 | ±0% | 29,700 |
| 2017/01/27 | 8,190 | 8,190 | 8,010 | 8,050 | -60 | -0.7% | 24,100 |
| 2017/01/26 | 8,100 | 8,160 | 8,070 | 8,110 | +100 | +1.2% | 23,600 |
| 2017/01/25 | 8,010 | 8,040 | 7,920 | 8,010 | +50 | +0.6% | 20,100 |
| 2017/01/24 | 7,950 | 8,060 | 7,930 | 7,960 | -70 | -0.9% | 13,500 |
| 2017/01/23 | 8,050 | 8,080 | 7,910 | 8,030 | -130 | -1.6% | 25,000 |
| 2017/01/20 | 8,130 | 8,220 | 8,120 | 8,160 | -20 | -0.2% | 24,400 |
| 2017/01/19 | 8,150 | 8,210 | 8,090 | 8,180 | +70 | +0.9% | 22,500 |
| 2017/01/18 | 8,260 | 8,260 | 8,080 | 8,110 | -100 | -1.2% | 17,300 |
| 2017/01/17 | 8,370 | 8,370 | 8,200 | 8,210 | -80 | -1% | 21,900 |
| 2017/01/16 | 8,230 | 8,320 | 8,190 | 8,290 | -20 | -0.2% | 20,400 |
| 2017/01/13 | 8,200 | 8,310 | 8,160 | 8,310 | +30 | +0.4% | 55,000 |
| 2017/01/12 | 8,460 | 8,460 | 8,240 | 8,280 | -250 | -2.9% | 40,200 |
| 2017/01/11 | 8,410 | 8,550 | 8,340 | 8,530 | +110 | +1.3% | 45,500 |
| 2017/01/10 | 8,450 | 8,520 | 8,370 | 8,420 | -30 | -0.4% | 37,500 |
| 2017/01/06 | 8,400 | 8,480 | 8,320 | 8,450 | +20 | +0.2% | 27,900 |
| 2017/01/05 | 8,410 | 8,480 | 8,340 | 8,430 | +170 | +2.1% | 50,900 |
| 2017/01/04 | 8,200 | 8,390 | 8,200 | 8,260 | +150 | +1.8% | 72,700 |
| 2016/12/30 | 8,110 | 8,130 | 8,060 | 8,110 | +20 | +0.2% | 25,200 |
| 2016/12/29 | 8,110 | 8,160 | 8,060 | 8,090 | -20 | -0.2% | 19,700 |
| 2016/12/28 | 8,160 | 8,160 | 8,070 | 8,110 | -50 | -0.6% | 13,800 |
| 2016/12/27 | 8,070 | 8,170 | 8,050 | 8,160 | +90 | +1.1% | 18,000 |
| 2016/12/26 | 8,050 | 8,140 | 8,000 | 8,070 | +100 | +1.3% | 36,700 |
| 2016/12/22 | 8,010 | 8,050 | 7,970 | 7,970 | -90 | -1.1% | 17,200 |
| 2016/12/21 | 8,100 | 8,140 | 8,040 | 8,060 | -60 | -0.7% | 29,400 |
| 2016/12/20 | 7,940 | 8,170 | 7,940 | 8,120 | +90 | +1.1% | 28,400 |
| 2016/12/19 | 7,970 | 8,030 | 7,960 | 8,030 | +70 | +0.9% | 40,200 |
| 2016/12/16 | 7,990 | 7,990 | 7,890 | 7,960 | +80 | +1% | 49,000 |
| 2016/12/15 | 7,900 | 7,940 | 7,840 | 7,880 | -20 | -0.3% | 34,200 |
| 2016/12/14 | 7,930 | 8,040 | 7,870 | 7,900 | -160 | -2% | 41,900 |
| 2016/12/13 | 7,770 | 8,080 | 7,710 | 8,060 | +280 | +3.6% | 48,300 |
| 2016/12/12 | 7,750 | 7,790 | 7,710 | 7,780 | +60 | +0.8% | 37,300 |
| 2016/12/09 | 7,780 | 7,810 | 7,660 | 7,720 | -130 | -1.7% | 45,700 |
| 2016/12/08 | 7,940 | 7,940 | 7,820 | 7,850 | -10 | -0.1% | 25,900 |
| 2016/12/07 | 7,820 | 7,880 | 7,810 | 7,860 | +90 | +1.2% | 34,900 |
| 2016/12/06 | 7,820 | 7,830 | 7,720 | 7,770 | +80 | +1% | 39,100 |
| 2016/12/05 | 7,810 | 7,810 | 7,630 | 7,690 | -150 | -1.9% | 32,500 |
| 2016/12/02 | 7,890 | 7,970 | 7,810 | 7,840 | -120 | -1.5% | 33,500 |
1901～
1950
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
